Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Описание течения инфекции COVID-19 у пациента с множественной коморбидной патологией: волосатоклеточным лейкозом, хронической формой генерализованного саркоидоза, тромбозом глубоких вен нижних конечностей. Клинический случай
________________________________________________
Kuklina GM, Makar'iants NN. Description of covid-19 infection course in a patient with multiple comorbidity: hairy cell leukemia, chronic generalized sarcoidosis and deep vein thrombosis in the lower extremities. Case report. Consilium Medicum. 2021; 23 (3): 292–295. DOI: 10.26442/20751753.2021.3.200815
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Ключевые слова: новая коронавирусная инфекция, волосатоклеточный лейкоз, саркоидоз
________________________________________________
This article presents an unusual case of a mild novel coronavirus infection COVID-19 in a patient with multiple comorbidity, including hairy cell leukemia, chronic generalized tuberculosis deep vein thrombosis in the legs which manifested with mild symptoms of general intoxication only.
Keywords: novel coronavirus infection, hairy cell leukemia, generalized sarcoidosis
2. Liang W, Guan W, Chen R, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020; 21 (3): 335–7.
3. Baumann T, Delgado J, Montserrat E. CLL and COVID-19 at the Hospital Clinic of Barcelona: an interim report. Leukemia. 2020; 34: 1–3.
4. Молочков А.В., Каратеев Д.Е., Огнева Е.Ю., и др. Коморбидные заболевания и прогнозирование исхода COVID-19: результаты наблюдения 13 585 больных, находившихся на стационарном лечении в больницах Московской области. Альманах клинической медицины. 2020; 48: 1–10 [Molochkov AV, Karateev DE, Ogneva EIu, et al. Komorbidnye zabolevaniia i prognozirovanie iskhoda COVID-19: rezul'taty nabliudeniia 13 585 bol'nykh, nakhodivshikhsia na statsionarnom lechenii v bol'nitsakh Moskovskoi oblasti. Al'manakh klinicheskoi meditsiny. 2020; 48: 1–10 (in Russian)]. DOI: 10.18786/2072-0505-2020-48-040
5. Hanna TP, Evans GA, Booth CM. Cancer, COVID-19 and the precautionary principle: prioritizing treatment during a global pandemic. Nat Rev Clin Oncol. 2020; 5: 268–70.
6. Dai M, Liu D, Liu M, et al. Patients with cancer appear more vulnerable to SARS-COV-2: a multicenter study during the COVID-19 outbreak. Cancer Discov. 2020; 10 (6): 783–91.
7. Robilotti EV, Babady NE, Kamboj M, et al. Determinants of COVID-19 disease severity in patients with cancer. Nat Med. 2020; 26 (8): 1218–23.
8. Ackermann M, Verleden SE, Kuehnel M, et al. Pulmonary Vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. New Engl J Med. 2020; 383 (2): 120–8. DOI: 10.1056/NEJMoa2015432
9. Временные методические рекомендации «Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19). Версия 7 (утв. Минздравом России 3 июня 2020 г.)». Режим доступа: https://base.garant.ru/74212510/. Ссылка активна на 05.06.2020 [Interim guidelines “Prevention, diagnosis and treatment of new coronavirus infection (COVID-19). Version 7 (approved by the Ministry of Health of Russia on June 3, 2020)”. Available at: https://base.garant.ru/74212510/. Accessed: 05.06.2020 (in Russian)].
________________________________________________
1. Adylkhanov TA, Kaidarova DR, Belikhina TI, Rakhmankulova AM. Klinicheskie osobennosti koronavirusnoi infektsii sredi patsientov s onkologicheskimi zabolevaniiami v Respublike Kazakhstan. Nauka i zdravookhranenie. 2020; 5 (22): 5–17 (in Russian)
DOI: 10.34689/SH.2020.22.5.001
2. Liang W, Guan W, Chen R, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020; 21 (3): 335–7.
3. Baumann T, Delgado J, Montserrat E. CLL and COVID-19 at the Hospital Clinic of Barcelona: an interim report. Leukemia. 2020; 34: 1–3.
4. Molochkov AV, Karateev DE, Ogneva EIu, et al. Komorbidnye zabolevaniia i prognozirovanie iskhoda COVID-19: rezul'taty nabliudeniia 13 585 bol'nykh, nakhodivshikhsia na statsionarnom lechenii v bol'nitsakh Moskovskoi oblasti. Al'manakh klinicheskoi meditsiny. 2020; 48: 1–10 (in Russian)
DOI: 10.18786/2072-0505-2020-48-040
5. Hanna TP, Evans GA, Booth CM. Cancer, COVID-19 and the precautionary principle: prioritizing treatment during a global pandemic. Nat Rev Clin Oncol. 2020; 5: 268–70.
6. Dai M, Liu D, Liu M, et al. Patients with cancer appear more vulnerable to SARS-COV-2: a multicenter study during the COVID-19 outbreak. Cancer Discov. 2020; 10 (6): 783–91.
7. Robilotti EV, Babady NE, Kamboj M, et al. Determinants of COVID-19 disease severity in patients with cancer. Nat Med. 2020; 26 (8): 1218–23.
8. Ackermann M, Verleden SE, Kuehnel M, et al. Pulmonary Vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. New Engl J Med. 2020; 383 (2): 120–8. DOI: 10.1056/NEJMoa2015432
9. Interim guidelines “Prevention, diagnosis and treatment of new coronavirus infection (COVID-19). Version 7 (approved by the Ministry of Health of Russia on June 3, 2020)”. Available at: https://base.garant.ru/74212510/. Accessed: 05.06.2020 (in Russian)
ФГБНУ «Центральный научно-исследовательский институт туберкулеза», Москва, Россия
*kgm74@mail.ru
________________________________________________
Galina M. Kuklina*, Natalia N. Makar'iants
Central Research Institute of Tuberculosis, Moscow, Russia
*kgm74@mail.ru